Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanwei Zhang

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
Clinical and Translational Medicine|May 31, 2023
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapyTianqing Chu, Jie Yuan, Jun Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 21, 2015
PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritisWei Zheng, Roscoe Warner, Roger Ruggeri, et al.
Journal of the American Heart Association|October 1, 2019
Hemodialysis Procedure-Associated Autonomic Imbalance and Cardiac Arrhythmias: Insights From Continuous 14-Day ECG MonitoringNichole M Rogovoy, Stacey J Howell, Tiffany L Lee, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Palmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosisXuewen Yang, Yanwei Zhang, Xiaoping Leng, et al.
Free Radical Biology & Medicine|January 31, 2026
TRIM28 aggravates myocardial infarction-induced cardiomyocyte apoptosis through regulating the stability of ATF5 via ubiquitination and SUMOylationYanying Wang, Mingyu Yang, Junting Ren, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 2023
China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopyYanwei Zhang, Fangfei Qian, Jiajun Teng, et al.
Signal Transduction and Targeted Therapy|September 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancerJun Lu, Minjuan Hu, Yikai Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 9, 2019
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung CancerJun Lu, Hua Zhong, Jun Wu, et al.
Translational Lung Cancer Research|August 12, 2022
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective studyTianqing Chu, Wei Zhang, Bo Zhang, et al.
Bioactive Materials|April 30, 2026
In situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMsDongping Liu, Mingyu Yang, Jie Liu, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Clinical and Translational Medicine|May 31, 2023
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapyTianqing Chu, Jie Yuan, Jun Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 21, 2015
PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritisWei Zheng, Roscoe Warner, Roger Ruggeri, et al.
Journal of the American Heart Association|October 1, 2019
Hemodialysis Procedure-Associated Autonomic Imbalance and Cardiac Arrhythmias: Insights From Continuous 14-Day ECG MonitoringNichole M Rogovoy, Stacey J Howell, Tiffany L Lee, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Palmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosisXuewen Yang, Yanwei Zhang, Xiaoping Leng, et al.
Free Radical Biology & Medicine|January 31, 2026
TRIM28 aggravates myocardial infarction-induced cardiomyocyte apoptosis through regulating the stability of ATF5 via ubiquitination and SUMOylationYanying Wang, Mingyu Yang, Junting Ren, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 2023
China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopyYanwei Zhang, Fangfei Qian, Jiajun Teng, et al.
Signal Transduction and Targeted Therapy|September 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancerJun Lu, Minjuan Hu, Yikai Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 9, 2019
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung CancerJun Lu, Hua Zhong, Jun Wu, et al.
Translational Lung Cancer Research|August 12, 2022
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective studyTianqing Chu, Wei Zhang, Bo Zhang, et al.
Bioactive Materials|April 30, 2026
In situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMsDongping Liu, Mingyu Yang, Jie Liu, et al.
Pageof 35